Vasoactive peptide release in relation to hemodynamic and metabolic changes during rapid ventricular pacing

PACE - Pacing and Clinical Electrophysiology

Volumn 22, Issue 7, 1999, Pages 1064-1070

  Ylitalo, Kari ^a   Uusimaa, Paavo ^a   Vuolteenaho, Olli ^a   Ruskoaho, Heikki ^a   Peuhkurinen, Keijo ^b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Endothelin; Ischemia; Natriuretic peptides; Ventricular pacing

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; LACTIC ACID; NORADRENALIN;

ADULT; ARTICLE; CARBON DIOXIDE TENSION; CLINICAL ARTICLE; CORONARY SINUS; FEMALE; FEMORAL ARTERY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE PACING; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; LUNG CAPILLARY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; METABOLISM; PH; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; ST SEGMENT DEPRESSION;

AGED; ANGINA PECTORIS; ATRIAL NATRIURETIC FACTOR; CARDIAC PACING, ARTIFICIAL; CORONARY DISEASE; ENDOTHELIN-1; ENERGY METABOLISM; FEMALE; HEART RATE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN;

EID: 0032772974     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1999.tb00571.x     Document Type: Article

References (35)

1. 1. Lang RE, Thölken H, Ganten D, et al. Atrial natriuretic factor - a circulating hormone stimulated by volume loading. Nature 1985; 314:264-266.
2. 2. Ruskoaho H. Atrial natriuretic peptide: Synthesis, release, and metabolism. Pharmacol Rev 1992; 44:479-602.
3. 3. Ogawa Y, Nakao K. Brain natriuretic peptide as a cardiac hormone in cardiovascular disorders. In JH Laragh, BM Brenner (eds.): Hypertension: Pathophysiology, Diagnosis, and Mangement. New York, NY, Raven Press Ltd., 1995, pp. 833-840.
4. 4. Levin ER. Endothelins. N Engl J Med 1995; 333:356-363.
5. 5. Schiffrin EL, Gutkowska J, Kuchel O, et al. Plasma concentration of atrial natriuretic factor in a patient with paroxysmal atrial tachycardia. N Engl J Med 1985; 312:1196-1197.
6. 6. Tikkanen I, Metsärinne K, Fyhrquist F. Atrial natriuretic peptide in paroxysmal supraventricular tachycardia. Lancet 1985; 11:40-41.
7. 7. Twidale N, Oliver JR, Menadue M, et al. Concentrations of plasma atrial natriuretic factor during and after reversion of ventricular tachycardia. Br Heart J 1900; 63:154-156.
8. 8. Cohen TJ, Liem LB. Neuroendocrine responses of ventricular tachycardia in humans. Am Heart J 1991; 121:1816-1818.
9. 9. Ellenbogen KA, Rogers R, Walsh M, et al. Increased circulating atrial natriuretic factor (ANF) release during induced ventricular tachycardia. Am Heart J 1988; 116:1233-1238.
10. 10. Fromer M, Razi M, Dubuc M, et al. Effect of ventricular tachycardia on atrial natriuretic peptide in humans. J Am Coll Cardiol 1988; 12:1395-1399.
11. 11. Walsh KP, Williams TDM, Canepa-Anson R, et al. Atrial natriuretic peptide released by rapid ventricular pacing in dogs does not cause a natriuresis. Clin Sci 1988; 74:571-576.
12. 12. Walsh KP, Williams TDM, Wilder R, et al. Decline of atrial natriuretic peptide release in dogs during sustained rapid cardiac pacing. Clin Sci 1988; 74:567-570.
13. 13. Peuhkurinen KJ, Huikuri HV, Ruskoaho H, et al. Blood pressure, plasma atrial natriuretic peptide and catecholamines during rapid ventricular pacing and effects of beta-adrenergic blockade in coronary artery disease. Am J Cardiol 1992; 69:35-39.
14. 14. Twidale N, Rayner TE, Menadue MF, et al. Atrial natriuretic factor release during rapid ventricular pacing: Interplay between autonomic and hemodynamic stimulants. Am Heart J 1993; 125:1638-1644.
15. 15. ØIE BK, Myking O, Hoff PI, et al. The acute effects of induced tachycardia on coronary sinus and arterial plasma levels of atrial natriuretic peptide and on arterial catecholamines. Scand J Clin Lab Invest 1994; 54:155-159.
16. 16. Berglund H, Edlund A, Theodorsson E, et al. Haemodynamic and hormonal responses to cardiac pacing in humans: Influence of different stimulation sequences and rates. Clin Sci 1995; 88:165-172.
17. 17. Peuhkurinen KJ, Uusimaa PA, Ruskoaho H, et al. Hemodynamic recovery, atrial natriuretic peptide, and catecholamines during simulated ventricular tachycardia: Effects of ventriculoatrial conduction. PACE 1995; 18:75-82.
18. 18. Magga J, Marttila M, Mäntymaa P, et al. Brain natriuretic peptide in plasma, atria and ventricles of vasopressin- and phenylephrine-infused conscious rats. Endocrinology 1994; 134:2505-2515.
19. 19. Moe GW, Grima EA, Wong NLM, et al. Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure. J Am Coll Cardiol 1996; 27:720-727.
20. 20. Rademaker MT, Charles CJ, Espiner EA, et al. Natriuretic peptide responses to acute and chronic ventricular pacing in sheep. Am J Physiol 1996; 270:H594-602.
21. 21. Vojacek J, Rohac J, Jindra A Jr, et al. Endothelin concentrations in coronary sinus during atrial pacing-induced myocardial ischemia. Cardiology 1994; 85:154-160.
22. 22. Vuolteenaho O, Koistinen P, Martikkala V, et al. Effect of physical exercise in hypobaric conditions on atrial natriuretic peptide secretion. Am J Physiol 1992; 263:R647-R652.
23. 23. Vuolteenaho O, Arjamaa O, Ling N. Atrial natriuretic polypeptide (ANP): Rat atria store high molecular weight precursor but secrete processed peptides of 25-35 amino acids. Biochem Biophys Res Commun 1985; 129:82-88.
24. 24. Pouta AM, Karinen J, Vuolteenaho O, et al. Effect of intravenous fluid preload on vasoactive peptide secretion during caesarean section under spinal anaesthesia. Anaesthesia 1996; 51:128-132.
25. 25. Crozier IG, Ikram H, Nicholls C. Hemodynamic and hormone changes during induced ventricular tachycardia secondary to coronary artery disease. Am J Cardiol 1989; 63:618-621.
26. 26. Schiebinger RJ, Linden J. Effect of atrial contraction frequency on atrial natriuretic peptide secretion. Am J Physiol 1986; 251:H1095-H1099.
27. 27. Uusimaa PA, Peuhkurinen KJ, Vuolteenaho O, et al. Role of myocardial redox and energy states in ischemia-stimulated release of atrial natriuretic peptide. J Mol Cell Cardiol 1992; 24:191-205.
28. 28. Uusimaa PA, Peuhkurinen KJ, Hassinen IE, et al. Ischemia stimulates the release of atrial natriuretic peptide from rat cardiac ventricular myocardium in vitro. Life Sci 1992; 50:365-373.
29. 29. Uusimaa PA, Ikäheimo MJ, Ruskoaho H, et al. Release of atrial natriuretic peptide in relation to metabolic changes during myocardial ischaemia induced by coronary angioplasty. Eur Heart J 1993; 14:682-686.
30. 30. deBold AJ, Bruneau BG, Kuroski de Bold ML. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 1996; 31:7-18.
31. 31. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, atrial natriurotic peptide and brain natriuretic peptide. J Clin Invest 1991; 87:1402-1412.
32. 32. Lang CC, Choy A-M, Turner K, et al. The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in man. J Hyportens 1993; 11:737-741.
33. 33. Suga S, Nakao K, Hosoda K, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-typc natriuretic peptide. Endocrinology 1992; 130:229-239.
34. 34. Stewart DJ, Kubac G, Costello KB, et al. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol 1991; 18:38-43.
35. 35. Fontana F, Tarsi G, Boschi S, et al. Relationships between plasma endothelin-1 levels and myocardial ischemia induced by exercise testing. Am J Cardiol 1997; 79:957-959.